Salvinorin B methoxymethyl ether: Difference between revisions
>Tracer Removed unnecessary categories |
>JDBauby m Added category "Terpenoid" |
||
| Line 9: | Line 9: | ||
===Experience reports=== | ===Experience reports=== | ||
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_Salvinorin_B_Ethoxymethyl_Ether.shtml Erowid Experience Vaults: Salvinorin B methoxymethyl ether] | |||
*[https://www.erowid.org/experiences/subs/exp_Salvinorin_B_Ethoxymethyl_Ether.shtml Erowid Experience Vaults: Salvinorin B methoxymethyl ether] | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Salvinorin A]] | *[[Salvinorin A]] | ||
| Line 18: | Line 20: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Salvinorin_B_methoxymethyl_ether Salvinorin B methoxymethyl ether (Wikipedia)] | *[https://en.wikipedia.org/wiki/Salvinorin_B_methoxymethyl_ether Salvinorin B methoxymethyl ether (Wikipedia)] | ||
*[https://www.erowid.org/chemicals/salvinorin_b_ethoxymethyl_ether/ Salvinorin B methoxymethyl ether (Erowid Vault)] | *[https://www.erowid.org/chemicals/salvinorin_b_ethoxymethyl_ether/ Salvinorin B methoxymethyl ether (Erowid Vault)] | ||
| Line 28: | Line 31: | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Salvinorin]] | [[Category:Salvinorin]] | ||
[[Category:Terpenoid]] | |||
Revision as of 15:24, 15 August 2022
 |
This article is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
| Summary sheet: Salvinorin B methoxymethyl ether |
| Salvinorin B methoxymethyl ether | |
|---|---|
 |
|
| Chemical Nomenclature | |
| Substitutive name | Salvinorin B |
| Systematic name | methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(furan-3-yl)-9-(methoxymethoxy)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate |
| Class Membership | |
| Psychoactive class | Hallucinogen |
| Chemical class | Salvinorin |
| Interactions | |
Salvinorin B methoxymethyl ether (2-O-methoxymethylsalvinorin B, or 2-MMSB) is a semi-synthetic analogue of the natural product Salvinorin A which is used in scientific research. It has a longer duration of action of around 2–3 hours, compared to less than 30 minutes for salvinorin A, and has increased affinity and potency at the κ-opioid receptor. Like the related compound herkinorin, salvinorin B methoxymethyl ether is made from salvinorin B, which is most conveniently made from salvinorin A by deacetylation, as while both salvinorin A and salvinorin B are found in the plant Salvia divinorum, salvinorin A is present in larger quantities.
Salvinorin B methoxymethyl ether has a Ki of 0.60 nM at the κ opioid receptor, and is around five times more potent than salvinorin A in animal studies, although it is still only half as potent as its stronger homolog salvinorin B ethoxymethyl ether.
Experience reports
There are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:
See also
External links
- Salvinorin B methoxymethyl ether (Wikipedia)
- Salvinorin B methoxymethyl ether (Erowid Vault)
- Salvinorin B methoxymethyl ether (TiHKAL / Isomer Design)
References
 |
This article does not cite enough references. You can help by adding some. |